MediciNova
MNOV
29 hedge funds and large institutions have $6.84M invested in MediciNova in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 4 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.46% less ownership
Funds ownership: 10.98% → 10.52% (-0.46%)
3% less funds holding
Funds holding: 30 → 29 (-1)
8% less capital invested
Capital invested by funds: $7.4M → $6.84M (-$569K)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$63.3K |
| 2 |
Renaissance Technologies
New York
|
+$21.3K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$14.4K |
| 4 |
FPAS
Focus Partners Advisor Solutions
Saint Louis,
Missouri
|
+$13.7K |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
+$9.05K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$165K |
| 2 |
Jane Street
New York
|
-$97.7K |
| 3 |
Goldman Sachs
New York
|
-$38.1K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$29.1K |
| 5 |
JP Morgan Chase
New York
|
-$28K |
MNOV Hedge Fund Activity: Q2 2026 in Review
29 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q2 2026, worth a combined $6.84M — down 7.7% from $7.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MNOV and 3 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 5 added.
The largest buyer was BlackRock, adding an estimated $63.3K. The largest seller was Barclays, cutting an estimated $165K.
- 29 institutional investors held MediciNova (MNOV) as of Q2 2026, down from 30 in Q1 2026.
- Funds reported $6.84M of MediciNova stock for Q2 2026, down 7.7% quarter-over-quarter.
- 3 funds opened new MediciNova positions in Q2 2026 and 4 closed out, a net change of -1 holder.
- The largest MediciNova buyer in Q2 2026 was BlackRock, an estimated $63.3K added.
- The largest MediciNova seller in Q2 2026 was Barclays, an estimated $165K sold.
Based on aggregated 13F filings for Q2 2026.